Back to search

University of Alabama Birmingham

Identifying Novel Therapeutics And Therapeutic Entry Points For The Treatment Of Duchenne Muscular Dystrophy Through Regulation Of Gene Expression

Abstract

dc:description.abstract

My graduate research has primarily focused on genetic and epigenetic modifiers of Duchenne muscular dystrophy and understanding how those modifiers can be used as novel therapeutic entry points for treatment. A vast array of promising therapeutic strategies is being explored outside the realm of directly targeting dystrophin deficiency. This is primarily due to the lack of successful clinical trials that have demonstrated the ability to benefit a significant number of DMD patients. Here, I have expanded the field’s understanding of using the regulation of gene expression as a way to target dystrophin-deficiency associated pathology through, 1) therapeutic treatment of a DMD mouse model using a novel SINE (Selective Inhibitor of Nuclear Export) compound, and 2) characterization of the role of a muscle-enriched microRNA, miR-486, in disease progression. I have demonstrated that inflammation-related DMD pathology can be subdued through indirect inhibition of the expression of inflammation-related genes via SINE compound KPT-350. In addition, I have uncovered novel targets of miR-486, which may be promising and viable targets for therapeutic intervention. Collectively, my studies on these modulators of gene expression have contributed to deepening the field’s understanding of potential avenues for uncovering promising therapeutic targets for DMD pathology.

Degree

thesis:*
Level thesis:degree_level
Dissertation

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hightower, Rylie Maria
Contributors dc:contributor
  • Matthew S Alexander
  • David A Schneider
  • Marcas M Bamman
  • Scott M Wilson
  • Jeremy J Day

Subjects

dc:subject × 5

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Hightower, Rylie Maria. Identifying Novel Therapeutics And Therapeutic Entry Points For The Treatment Of Duchenne Muscular Dystrophy Through Regulation Of Gene Expression. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/807